Replies to post #722202 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

manibiotech,

Walgreens already mentioned DCVax-L and has built a new facility capable of handling cell therapy storage and distribution. You might want to ask a higher up Walgreens rep about how they might be planning to utilize their new facility with regard to murcidencel before you make your bet; ). Best wishes.

[attilathehunt]

Walgreen or CVS will not be dispensing DCVax .

What about them drawing blood to send off to make DCVax-D?

[dstock07734]

This is what Warren Buffett said. You should stop digging and bail.

"The most important thing to do if you find yourself in a hole is to stop digging."

[scotty3371]

Patients can pay at the self checkout terminal!!!!

[SkyLimit2022]

mani,

The Walgreens Pittsburgh facility is just a start. Cell-based therapies represent a relatively new and rapidly expanding area of research and development. The U.S. NIH, FDA, and other government agencies are expecting private industry to get onboard, and companies involved in healthcare delivery want to get onboard to sustain and grow their market share.

Cancer immunotherapy is projected to exceed 150 billion globally, and cell-based therapies and therapy combos will capture a large portion of that expanding market.

For example, PD-1 represents a drug class with a huge market share, so a new technology that pairs well with PD-1 technology could very well become huge too. If a technology such as the DCVax-L platform can enhance or unlock the efficacy of PD-1 blockade and other technologies, then it will have a ready-made foothold in a rapidly expanding market.

⭐️Combo is King!⭐️




https://www.prnewswire.com/news-releases/cancer-immunotherapy-market-worth-196-45-billion-by-2030-grand-view-research-inc-301724510.html

https://www.cnbc.com/2024/04/25/walgreens-launches-cell-gene-therapies-in-service-expansion.html

https://finance.yahoo.com/news/global-immune-checkpoint-inhibitors-market-142600613.html/